First-in-human data of ALLO-501A, an allogeneic chimeric antigen receptor (CAR) T-cell therapy and ALLO-647 in relapsed/refractory large B-cell lymphoma (R/R LBCL): ALPHA2 study.
暂无分享,去创建一个
L. Lekakis | S. Neelapu | F. Locke | J. Abramson | M. Tees | J. McDevitt | L. Popplewell | C. Konto | Eren Demirhan | C. R. Shin | Shahbaz Malik